Literature DB >> 9643306

Evaluating noise induced hearing loss with distortion product otoacoustic emissions.

J Attias1, I Bresloff, I Reshef, G Horowitz, V Furman.   

Abstract

This study assessed the clinical efficacy of screening for noise induced hearing loss (NIHL) with distortion product otoacoustic emissions (DPOAE). DPOAEs were recorded from 76 military personnel (137 ears) aged between 17 and 41 years in response to equilevel 70 dB SPL primary stimulating tones. The 2f1-f2 DPOAE levels were correlated with audiometric thresholds at frequencies close to f2. Ears with normal audiograms, but with a history of military noise exposure, had DPOAEs that were significantly decreased in amplitude as compared to the ears of normal hearing non-exposed to noise subjects. These ears also had an increased absence of DPOAEs as compared with the ears of the normal hearing non-exposed to noise subjects. Although, in general, the DPOAE amplitudes and spectral frequency ranges reflected the audiometric NIHL configurations, in a number of cases DPOAEs were present for hearing losses up to 75 dB HL. As a consequence, DPOAEs correlated moderately and negatively with the audiometric thresholds. Applying test criteria designed to logically reflect NIHL, DPOAE sensitivity and specificity levels ranged between 0.51-0.90 and 0.63-0.25, respectively. These findings indicate that DPOAEs, recorded and analysed as described, are not sufficiently sensitive to serve as a single test to identify NIHL.

Entities:  

Mesh:

Year:  1998        PMID: 9643306     DOI: 10.3109/03005364000000049

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  9 in total

1.  Distortion Product Otoacoustic Emissions in Screening for Early Stages of High-frequency Hearing Loss in Adolescents.

Authors:  Danique E Paping; Marc van der Schroef; Hiske W Helleman; André Goedegebure; Rob J Baatenburg de Jong; Jantien L Vroegop
Journal:  Noise Health       Date:  2022 Jan-Mar       Impact factor: 1.293

2.  Amplitude-modulation detection by recreational-noise-exposed humans with near-normal hearing thresholds and its medium-term progression.

Authors:  Michael A Stone; Brian C J Moore
Journal:  Hear Res       Date:  2014-09-27       Impact factor: 3.208

3.  Modeling signal-to-noise ratio of otoacoustic emissions in workers exposed to different industrial noise levels.

Authors:  Parvin Nassiri; Sajad Zare; Mohammad R Monazzam; Akram Pourbakht; Kamal Azam; Taghi Golmohammadi
Journal:  Noise Health       Date:  2016 Nov-Dec       Impact factor: 0.867

Review 4.  Occupational Noise: Auditory and Non-Auditory Consequences.

Authors:  Adam Sheppard; Massimo Ralli; Antonio Gilardi; Richard Salvi
Journal:  Int J Environ Res Public Health       Date:  2020-12-02       Impact factor: 3.390

5.  Oleuropein Effect on Noise-Induced Hearing Loss.

Authors:  Özgür Kümüş; Yüksel Olgun; Serpil Mungan Durankaya; Safiye Aktaş; Günay Kirkim; Semih Sütay
Journal:  J Int Adv Otol       Date:  2022-03       Impact factor: 1.316

6.  Subclinical Hearing Deficits in Noise-Exposed Firefighters.

Authors:  Hillary A Snapp; Natasha Schaefer Solle; Barbara Millet; Suhrud M Rajguru
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

7.  Evaluation of Distortion Product Otoacoustic Emissions (DPOAEs) among workers at an Industrial Company exposed to different industrial noise levels in 2014.

Authors:  Sajad Zare; Parvin Nassiri; Mohammad Reza Monazzam; Akram Pourbakht; Kamal Azam; Taghi Golmohammadi
Journal:  Electron Physician       Date:  2015-07-20

8.  Cochlear dysfunction is associated with styrene exposure in humans.

Authors:  Mariola Sliwinska-Kowalska; Adrian Fuente; Ewa Zamyslowska-Szmytke
Journal:  PLoS One       Date:  2020-01-21       Impact factor: 3.240

9.  Threshold Equalizing Noise Test Reveals Suprathreshold Loss of Hearing Function, Even in the "Normal" Audiogram Range.

Authors:  Michael A Stone; Emanuele Perugia; Warren Bakay; Melanie Lough; Helen Whiston; Christopher J Plack
Journal:  Ear Hear       Date:  2022-03-11       Impact factor: 3.562

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.